Loyal

We’re teaming up because senior dogs deserve more. We're partnering with the Senior Dog Veterinary Society to bring veterinarians expert education on aging, care strategies, and the latest science behind extending healthspan in senior dogs. We’re offering veterinary professionals a free, live CE webinar on Apr. 9 at 5pm PT / 8pm ET so you can learn about the biology of aging and how to set up senior care programs for dogs in your practice. Register for free at https://loyal.com/sdvs-ce. To read more about our partnership, visit https://lnkd.in/gpjKE-PM.

Meet the team behind Loyal! We’re proud of the work we do and have an incredible team making it happen. From vets to scientists to problem solvers, here are a few of the dog lovers bringing our mission to life.?→ loyal.com/team-spotlight Thanks, Brennen McKenzie, Ashley Tovar, PhD, RD, and Laura Vasquez-Bolanos, PhD, for sharing your love of dogs with us.

Meet the team behind Loyal! We’re proud of the work we do and have an incredible team making it happen. From vets to scientists to problem solvers, here are a few of the dog lovers bringing our mission to life.?→ loyal.com/team-spotlight Thanks, Brennen McKenzie, Ashley Tovar, PhD, RD, and Laura Vasquez-Bolanos, PhD, for sharing your love of dogs with us.

What do vets think LOY-002's recent FDA progress could mean for patient care? Dr. Brennen McKenzie, our Director of Vet Medicine, spends half of his time in clinical practice, where he sees the limits aging imposes on his patients firsthand. Here’s what Dr. Brennen and other vets have to say about LOY-002’s preliminary efficacy nod (RXE) and its potential to change the way vets practice → loyal.com/rxe-for-vets

It was a big week at Loyal! We're so excited to celebrate our progress towards creating the first-ever FDA-approved longevity drugs for dogs. Here are some highlights: The Washington Post: https://lnkd.in/gK3h6Jy9 dvm360?: https://lnkd.in/gm5k_Htg The Today Show: https://lnkd.in/gBT8nNth The Late Show with Stephen Colbert: https://lnkd.in/gsuJziuE

Good news for senior dogs! ?? Our senior dog drug, LOY-002, completed its preliminary FDA efficacy package (RXE). This is a crucial step towards bringing the first longevity drug to dog owners and veterinarians in the next year. What this means: we’re on track to receive FDA conditional approval in late 2025 and launch the first drug developed to give senior dogs more healthy time. A word from our CEO → loyal.com/RXE

"My goal is that every eligible dog is on a longevity drug for them to be healthy longer," said our founder and CEO?Celine Halioua to Lisa Bonos of The Washington Post. Today's milestone is an important step towards making an FDA-approved longevity drug a reality this year, and we're thrilled to share our progress. Read the full story: https://lnkd.in/gK3h6Jy9

Heading to WVC 2025? Meet us at Booth 3046 to learn how we’re developing longevity drugs for dogs and try your luck with our scratch tickets for a chance to win a Loyal prize while supplies last. We're also offering multiple CE sessions on canine aging — add them to your calendar now: https://lnkd.in/g5NGJe6s ? #WVC2025 #VeterinaryMedicine #CanineAging #Longevity

Are you a leader that thrives in a start-up environment, with experience commercializing a small molecule drug product? We're seeking a Senior Director of CMC & DP to oversee all aspects of the commercial manufacturing of our first longevity drug for dogs. Apply here?→?https://lnkd.in/g-Yxfu_D

“Their lifespans are never long enough.” We couldn’t agree more – and that’s why we’re developing the first longevity drugs for dogs. Hear more from Gabriela Vidal of CBS News Colorado who visited one of our clinical trial sites in Denver to learn more about how we’re working with vets across the country to extend both the quantity and quality of time we get to spend with our favorite four-legged companions: https://lnkd.in/ggq3sddR